Regenxbio Inc (RGNX)
7.63
+0.22
(+2.97%)
USD |
NASDAQ |
Dec 20, 16:00
7.71
+0.08
(+1.05%)
After-Hours: 20:00
Regenxbio Profit Margin (Quarterly): -246.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 34.10% |
| Vertex Pharmaceuticals Inc | 37.71% |
| Sarepta Therapeutics Inc | 7.19% |
| Edgewise Therapeutics Inc | -- |
| Entrada Therapeutics Inc | -71.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.61% |
| Return on Assets | -40.81% |
| Return on Invested Capital | -69.61% |
| Gross Profit Margin (Quarterly) | 48.81% |
| Operating Margin (Quarterly) | -256.6% |
| Return on Net Operating Assets | -106.8% |